Wayne G Shreffler, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peanut Hypersensitivity | 42 | 2024 | 219 | 8.300 |
Why?
|
Food Hypersensitivity | 39 | 2024 | 734 | 6.470 |
Why?
|
Allergens | 60 | 2024 | 1444 | 5.180 |
Why?
|
Desensitization, Immunologic | 30 | 2024 | 558 | 4.630 |
Why?
|
Immunoglobulin E | 44 | 2024 | 1506 | 3.480 |
Why?
|
Antigens, Plant | 14 | 2023 | 104 | 2.570 |
Why?
|
Th2 Cells | 13 | 2024 | 1079 | 2.530 |
Why?
|
Basophils | 11 | 2022 | 407 | 2.480 |
Why?
|
Milk Hypersensitivity | 13 | 2024 | 83 | 2.130 |
Why?
|
Eosinophilic Esophagitis | 8 | 2024 | 205 | 2.110 |
Why?
|
2S Albumins, Plant | 10 | 2023 | 37 | 2.060 |
Why?
|
Basophil Degranulation Test | 4 | 2019 | 20 | 1.830 |
Why?
|
Anaphylaxis | 9 | 2024 | 758 | 1.650 |
Why?
|
Anti-Allergic Agents | 6 | 2024 | 157 | 1.510 |
Why?
|
Hypersensitivity | 9 | 2024 | 1173 | 1.200 |
Why?
|
Proctocolitis | 6 | 2024 | 31 | 1.120 |
Why?
|
Plant Proteins | 9 | 2023 | 376 | 1.040 |
Why?
|
Immunoassay | 5 | 2017 | 746 | 0.980 |
Why?
|
Glycoproteins | 7 | 2015 | 2202 | 0.960 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2022 | 812 | 0.930 |
Why?
|
Immune Tolerance | 11 | 2024 | 2323 | 0.910 |
Why?
|
Complementarity Determining Regions | 2 | 2021 | 154 | 0.760 |
Why?
|
Administration, Oral | 20 | 2024 | 4040 | 0.750 |
Why?
|
Cytokines | 9 | 2024 | 7453 | 0.740 |
Why?
|
Retinal Dehydrogenase | 1 | 2020 | 78 | 0.730 |
Why?
|
Epitope Mapping | 6 | 2011 | 300 | 0.720 |
Why?
|
Adjuvants, Immunologic | 3 | 2012 | 999 | 0.670 |
Why?
|
Hypersensitivity, Immediate | 5 | 2017 | 349 | 0.650 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.640 |
Why?
|
Skin Tests | 17 | 2023 | 639 | 0.610 |
Why?
|
Immunologic Memory | 3 | 2021 | 1378 | 0.600 |
Why?
|
Immunity, Innate | 6 | 2021 | 3080 | 0.590 |
Why?
|
Microarray Analysis | 4 | 2011 | 755 | 0.590 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2024 | 3116 | 0.580 |
Why?
|
Epitopes | 10 | 2023 | 2529 | 0.580 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 962 | 0.560 |
Why?
|
Diet Therapy | 1 | 2017 | 150 | 0.540 |
Why?
|
Enterocolitis | 3 | 2023 | 106 | 0.510 |
Why?
|
Immunoglobulin G | 10 | 2016 | 4568 | 0.510 |
Why?
|
Flow Cytometry | 4 | 2017 | 5906 | 0.500 |
Why?
|
Metabolomics | 1 | 2024 | 1675 | 0.490 |
Why?
|
Child, Preschool | 45 | 2024 | 42683 | 0.470 |
Why?
|
Food | 6 | 2023 | 768 | 0.470 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 313 | 0.450 |
Why?
|
Immunization | 3 | 2019 | 1220 | 0.440 |
Why?
|
Child | 54 | 2024 | 80960 | 0.430 |
Why?
|
Vitamin A | 1 | 2015 | 611 | 0.400 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2574 | 0.400 |
Why?
|
Milk Proteins | 5 | 2024 | 161 | 0.390 |
Why?
|
Amino Acid Sequence | 5 | 2021 | 13427 | 0.390 |
Why?
|
Infant Formula | 1 | 2013 | 195 | 0.380 |
Why?
|
Feeding Methods | 1 | 2011 | 35 | 0.380 |
Why?
|
Dendritic Cells | 3 | 2020 | 2748 | 0.380 |
Why?
|
Weaning | 1 | 2011 | 102 | 0.380 |
Why?
|
Drug Utilization | 2 | 2014 | 1191 | 0.380 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2010 | 85 | 0.370 |
Why?
|
Humans | 125 | 2024 | 768970 | 0.370 |
Why?
|
Infant Food | 1 | 2011 | 139 | 0.370 |
Why?
|
Infant | 33 | 2024 | 36556 | 0.370 |
Why?
|
Integrins | 1 | 2015 | 843 | 0.360 |
Why?
|
Vaccines | 1 | 2018 | 843 | 0.330 |
Why?
|
Egg Hypersensitivity | 4 | 2012 | 47 | 0.330 |
Why?
|
Dietary Proteins | 4 | 2024 | 960 | 0.320 |
Why?
|
Eczema | 3 | 2021 | 245 | 0.310 |
Why?
|
Cesarean Section | 2 | 2014 | 1426 | 0.310 |
Why?
|
Intestines | 2 | 2014 | 1911 | 0.310 |
Why?
|
Animal Technicians | 2 | 2018 | 7 | 0.310 |
Why?
|
Food Labeling | 2 | 2023 | 181 | 0.300 |
Why?
|
Dose-Response Relationship, Immunologic | 4 | 2018 | 361 | 0.300 |
Why?
|
Immunomodulation | 2 | 2024 | 549 | 0.290 |
Why?
|
Immunotherapy | 3 | 2024 | 4756 | 0.290 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10276 | 0.290 |
Why?
|
Epinephrine | 3 | 2024 | 794 | 0.280 |
Why?
|
Complement Activation | 1 | 2009 | 447 | 0.280 |
Why?
|
Receptors, IgE | 4 | 2020 | 375 | 0.270 |
Why?
|
Cell Adhesion Molecules | 2 | 2018 | 1614 | 0.270 |
Why?
|
Intestinal Mucosa | 2 | 2016 | 3044 | 0.270 |
Why?
|
Nut Hypersensitivity | 2 | 2019 | 33 | 0.260 |
Why?
|
HLA-DQ Antigens | 1 | 2006 | 190 | 0.260 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4794 | 0.250 |
Why?
|
Antigens, Differentiation | 1 | 2009 | 921 | 0.250 |
Why?
|
Complement System Proteins | 1 | 2009 | 738 | 0.250 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9264 | 0.240 |
Why?
|
Cells, Cultured | 8 | 2024 | 19023 | 0.240 |
Why?
|
Antibody Formation | 2 | 2022 | 1393 | 0.240 |
Why?
|
HLA-DR Antigens | 1 | 2006 | 609 | 0.230 |
Why?
|
Vitamin D | 2 | 2015 | 3311 | 0.230 |
Why?
|
Antibody Specificity | 5 | 2011 | 1065 | 0.230 |
Why?
|
Adolescent | 30 | 2024 | 89244 | 0.230 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
Biological Assay | 1 | 2006 | 628 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Male | 55 | 2024 | 365203 | 0.220 |
Why?
|
Animals | 28 | 2024 | 169335 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Lectins, C-Type | 1 | 2006 | 593 | 0.210 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5505 | 0.210 |
Why?
|
Eicosanoids | 1 | 2024 | 284 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 201 | 0.200 |
Why?
|
Administration, Cutaneous | 3 | 2020 | 716 | 0.200 |
Why?
|
Eosinophils | 3 | 2018 | 953 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 399 | 0.200 |
Why?
|
Enteritis | 1 | 2023 | 164 | 0.200 |
Why?
|
Algorithms | 4 | 2017 | 14201 | 0.190 |
Why?
|
Gastritis | 1 | 2023 | 199 | 0.190 |
Why?
|
Food Analysis | 1 | 2022 | 103 | 0.190 |
Why?
|
Milk | 4 | 2013 | 438 | 0.190 |
Why?
|
Occupational Exposure | 3 | 2018 | 1807 | 0.190 |
Why?
|
Female | 50 | 2024 | 397515 | 0.190 |
Why?
|
Biological Products | 2 | 2022 | 947 | 0.190 |
Why?
|
Protein Array Analysis | 5 | 2011 | 400 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 1855 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2021 | 104 | 0.180 |
Why?
|
Aptamers, Nucleotide | 1 | 2022 | 163 | 0.180 |
Why?
|
Anti-Asthmatic Agents | 2 | 2016 | 577 | 0.180 |
Why?
|
Double-Blind Method | 8 | 2020 | 12467 | 0.170 |
Why?
|
Receptors, Peptide | 1 | 2021 | 280 | 0.170 |
Why?
|
Constipation | 1 | 2024 | 570 | 0.170 |
Why?
|
Child Development | 1 | 2011 | 2336 | 0.170 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2020 | 175 | 0.170 |
Why?
|
Pyrophosphatases | 2 | 2012 | 142 | 0.160 |
Why?
|
Signal Transduction | 2 | 2012 | 23653 | 0.160 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2022 | 352 | 0.160 |
Why?
|
Th1-Th2 Balance | 1 | 2018 | 38 | 0.160 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7478 | 0.160 |
Why?
|
Eosinophilia | 1 | 2023 | 556 | 0.160 |
Why?
|
Serologic Tests | 1 | 2021 | 382 | 0.160 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 2012 | 205 | 0.160 |
Why?
|
Population Groups | 1 | 2019 | 208 | 0.150 |
Why?
|
Lymphokines | 1 | 2021 | 927 | 0.150 |
Why?
|
Endotoxins | 2 | 2017 | 520 | 0.150 |
Why?
|
Seed Storage Proteins | 2 | 2010 | 15 | 0.150 |
Why?
|
Egg White | 2 | 2008 | 16 | 0.150 |
Why?
|
Documentation | 1 | 2024 | 917 | 0.150 |
Why?
|
Tretinoin | 1 | 2020 | 525 | 0.150 |
Why?
|
Peptides | 2 | 2009 | 4353 | 0.140 |
Why?
|
Air Pollutants, Occupational | 2 | 2017 | 406 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2024 | 65480 | 0.140 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2820 | 0.140 |
Why?
|
Confidence Intervals | 2 | 2020 | 2932 | 0.140 |
Why?
|
Mast Cells | 3 | 2019 | 1406 | 0.140 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 977 | 0.130 |
Why?
|
Biotechnology | 1 | 2018 | 283 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.130 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2542 | 0.130 |
Why?
|
Chemokines, CC | 2 | 2013 | 286 | 0.130 |
Why?
|
Cross Reactions | 1 | 2017 | 828 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3810 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 587 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 840 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3671 | 0.120 |
Why?
|
Budesonide | 1 | 2015 | 162 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2022 | 14752 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4413 | 0.110 |
Why?
|
Asthma | 3 | 2023 | 6293 | 0.110 |
Why?
|
Membrane Proteins | 5 | 2022 | 7885 | 0.110 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 64 | 0.110 |
Why?
|
Receptors, CCR8 | 1 | 2013 | 28 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1248 | 0.110 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2013 | 100 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 358 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2017 | 702 | 0.100 |
Why?
|
Probiotics | 1 | 2016 | 383 | 0.100 |
Why?
|
Adult | 24 | 2024 | 223851 | 0.100 |
Why?
|
Eating | 1 | 2019 | 1542 | 0.100 |
Why?
|
Histamine Release | 1 | 2012 | 134 | 0.100 |
Why?
|
Soy Foods | 1 | 2012 | 44 | 0.100 |
Why?
|
Clone Cells | 1 | 2015 | 1670 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4290 | 0.090 |
Why?
|
Juglans | 1 | 2011 | 45 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2603 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 395 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1762 | 0.090 |
Why?
|
Cell Differentiation | 3 | 2024 | 11684 | 0.090 |
Why?
|
Lens Plant | 1 | 2010 | 5 | 0.090 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11932 | 0.090 |
Why?
|
Plants | 1 | 2012 | 332 | 0.090 |
Why?
|
Parents | 1 | 2024 | 3597 | 0.090 |
Why?
|
Adrenergic Agonists | 1 | 2009 | 57 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2010 | 253 | 0.080 |
Why?
|
Treatment Failure | 1 | 2015 | 2664 | 0.080 |
Why?
|
Lactoglobulins | 1 | 2008 | 22 | 0.080 |
Why?
|
Up-Regulation | 1 | 2018 | 4148 | 0.080 |
Why?
|
Meat | 1 | 2012 | 588 | 0.080 |
Why?
|
Cell Degranulation | 2 | 2020 | 277 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2012 | 564 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 1048 | 0.080 |
Why?
|
Caseins | 1 | 2008 | 105 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6512 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9621 | 0.080 |
Why?
|
Interleukin-3 | 1 | 2009 | 425 | 0.070 |
Why?
|
Cattle | 3 | 2024 | 3819 | 0.070 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2009 | 355 | 0.070 |
Why?
|
Nutrition Policy | 1 | 2011 | 467 | 0.070 |
Why?
|
Phytohemagglutinins | 1 | 2006 | 165 | 0.070 |
Why?
|
Mice | 9 | 2024 | 82072 | 0.070 |
Why?
|
Dermatitis, Atopic | 2 | 2011 | 737 | 0.070 |
Why?
|
Gene Expression | 3 | 2015 | 7603 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2009 | 605 | 0.070 |
Why?
|
Urticaria | 1 | 2008 | 151 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18435 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1338 | 0.070 |
Why?
|
Mitogens | 1 | 2006 | 229 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8559 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2015 | 10486 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3562 | 0.070 |
Why?
|
Urban Population | 2 | 2017 | 2046 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2015 | 2167 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1276 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4651 | 0.060 |
Why?
|
Young Adult | 11 | 2024 | 60131 | 0.060 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 342 | 0.060 |
Why?
|
United States | 7 | 2024 | 73186 | 0.060 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2006 | 283 | 0.060 |
Why?
|
Blood Specimen Collection | 1 | 2006 | 238 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1638 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Syndrome | 2 | 2023 | 3274 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2222 | 0.060 |
Why?
|
Thyroid Diseases | 1 | 2008 | 385 | 0.060 |
Why?
|
Environmental Exposure | 2 | 2017 | 4544 | 0.060 |
Why?
|
Ligands | 2 | 2013 | 3283 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 30046 | 0.060 |
Why?
|
Laxatives | 1 | 2024 | 95 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2022 | 22296 | 0.050 |
Why?
|
Reference Standards | 1 | 2006 | 1014 | 0.050 |
Why?
|
Environment | 1 | 2009 | 1122 | 0.050 |
Why?
|
Prospective Studies | 7 | 2024 | 54962 | 0.050 |
Why?
|
Immunologic Factors | 2 | 2022 | 1597 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1252 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2010 | 17629 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2006 | 1342 | 0.050 |
Why?
|
Powders | 1 | 2021 | 79 | 0.050 |
Why?
|
Emollients | 1 | 2021 | 42 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2024 | 3215 | 0.050 |
Why?
|
Cryopreservation | 1 | 2006 | 734 | 0.050 |
Why?
|
Risk Factors | 7 | 2022 | 74976 | 0.050 |
Why?
|
Antigens | 1 | 2006 | 1444 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3438 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2024 | 12806 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15879 | 0.040 |
Why?
|
Nuts | 1 | 2022 | 264 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7460 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1813 | 0.040 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2019 | 25 | 0.040 |
Why?
|
Neuraminidase | 1 | 2020 | 196 | 0.040 |
Why?
|
Fetal Blood | 1 | 2006 | 1361 | 0.040 |
Why?
|
Cell Line | 4 | 2019 | 15604 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 89 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 110 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 610 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6346 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2210 | 0.040 |
Why?
|
ROC Curve | 2 | 2021 | 3629 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2013 | 3702 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 13510 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 538 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 992 | 0.040 |
Why?
|
Occult Blood | 1 | 2020 | 199 | 0.040 |
Why?
|
Antigens, CD | 2 | 2006 | 4032 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 41808 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2023 | 26428 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1154 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2005 | 2732 | 0.040 |
Why?
|
Hot Temperature | 3 | 2010 | 1441 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39394 | 0.040 |
Why?
|
Animals, Laboratory | 1 | 2017 | 46 | 0.040 |
Why?
|
Models, Immunological | 1 | 2020 | 518 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 223737 | 0.040 |
Why?
|
Respiratory System | 1 | 2021 | 565 | 0.040 |
Why?
|
Diet | 1 | 2015 | 8088 | 0.040 |
Why?
|
Galectin 3 | 1 | 2019 | 240 | 0.040 |
Why?
|
Plant Extracts | 1 | 2021 | 499 | 0.030 |
Why?
|
Glycosylation | 1 | 2020 | 1101 | 0.030 |
Why?
|
Medical History Taking | 1 | 2021 | 779 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 899 | 0.030 |
Why?
|
Conjunctivitis, Allergic | 1 | 2017 | 124 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2010 | 1157 | 0.030 |
Why?
|
Protein Binding | 2 | 2022 | 9344 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1042 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 2258 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2017 | 272 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 518 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3214 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10400 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2041 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15951 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 791 | 0.030 |
Why?
|
Cities | 1 | 2017 | 543 | 0.030 |
Why?
|
Dust | 1 | 2017 | 488 | 0.030 |
Why?
|
Maine | 1 | 2013 | 146 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3447 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12562 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9527 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6214 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9684 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2009 | 0.030 |
Why?
|
Leukotriene B4 | 1 | 2013 | 281 | 0.030 |
Why?
|
DNA | 1 | 2006 | 7214 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 381 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 81903 | 0.020 |
Why?
|
Housing | 1 | 2017 | 683 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1672 | 0.020 |
Why?
|
HIV Infections | 1 | 2018 | 17591 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2011 | 60 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9499 | 0.020 |
Why?
|
Eggs | 1 | 2012 | 182 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2013 | 660 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 705 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 610 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 600 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2013 | 439 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1204 | 0.020 |
Why?
|
Laboratories | 1 | 2013 | 463 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2339 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2945 | 0.020 |
Why?
|
Interleukin-5 | 1 | 2010 | 267 | 0.020 |
Why?
|
Weight Gain | 1 | 2020 | 2359 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18354 | 0.020 |
Why?
|
Ovomucin | 1 | 2008 | 7 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5793 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6547 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1989 | 0.020 |
Why?
|
Pruritus | 1 | 2010 | 379 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9565 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9377 | 0.020 |
Why?
|
Ovalbumin | 1 | 2008 | 677 | 0.020 |
Why?
|
Egg Proteins, Dietary | 1 | 2006 | 6 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10633 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9549 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14794 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5216 | 0.020 |
Why?
|
Phylogeny | 1 | 2013 | 2843 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5763 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20245 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3346 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 18068 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1757 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13674 | 0.010 |
Why?
|
Pregnancy | 2 | 2020 | 30265 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3956 | 0.010 |
Why?
|
Aged | 3 | 2020 | 171786 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16731 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2942 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22379 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5404 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5792 | 0.010 |
Why?
|
Feces | 1 | 2006 | 1510 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4592 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10765 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24333 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59739 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10868 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21547 | 0.010 |
Why?
|